| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1109853
[patent_doc_number] => 06805869
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-19
[patent_title] => 'Cellular vaccines and immunotherapeutics and methods for their preparation'
[patent_app_type] => B2
[patent_app_number] => 09/216604
[patent_app_country] => US
[patent_app_date] => 1998-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19400
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/805/06805869.pdf
[firstpage_image] =>[orig_patent_app_number] => 09216604
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/216604 | Cellular vaccines and immunotherapeutics and methods for their preparation | Dec 16, 1998 | Issued |
| 09/210490 | WATER-SOLUBLE GLOBULIN CONCENTRATE FOR IMPROVING GROWTH IN ANIMALS | Dec 10, 1998 | Abandoned |
Array
(
[id] => 6406897
[patent_doc_number] => 20020182725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'NEW ANTIGEN PRESENTING CELLS, A PROCESS FOR PREPARING THE SAME AND THEIR USE AS CELLULAR VACCINES'
[patent_app_type] => new
[patent_app_number] => 09/194053
[patent_app_country] => US
[patent_app_date] => 1998-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6774
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182725.pdf
[firstpage_image] =>[orig_patent_app_number] => 09194053
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/194053 | NEW ANTIGEN PRESENTING CELLS, A PROCESS FOR PREPARING THE SAME AND THEIR USE AS CELLULAR VACCINES | Nov 22, 1998 | Abandoned |
| 09/189577 | METHOD AND COMPOSITIONS FOR IMPROVING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION | Nov 10, 1998 | Abandoned |
| 09/171562 | AUTOANTIGEN AND PROTEINS STRUCTURALLY RELATED THERETO FOR USE IN IMMUNOTHERAPHY OF AUTOIMMUNE DISEASES | Oct 18, 1998 | Abandoned |
Array
(
[id] => 1363109
[patent_doc_number] => 06569838
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-27
[patent_title] => 'Facilitation of keloid healing with CM101/GBS toxin'
[patent_app_type] => B1
[patent_app_number] => 09/167774
[patent_app_country] => US
[patent_app_date] => 1998-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5027
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/569/06569838.pdf
[firstpage_image] =>[orig_patent_app_number] => 09167774
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/167774 | Facilitation of keloid healing with CM101/GBS toxin | Oct 6, 1998 | Issued |
Array
(
[id] => 4177399
[patent_doc_number] => 06149906
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Antigen presenting cells of the adipocyte lineage'
[patent_app_type] => 1
[patent_app_number] => 9/157008
[patent_app_country] => US
[patent_app_date] => 1998-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 8562
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/149/06149906.pdf
[firstpage_image] =>[orig_patent_app_number] => 157008
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/157008 | Antigen presenting cells of the adipocyte lineage | Sep 17, 1998 | Issued |
Array
(
[id] => 5921156
[patent_doc_number] => 20020114816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'AUTOREACTIVE PEPTIDES FROM HUMAN GLUTAMIC ACID-DECARBOXYLASE (GAD)'
[patent_app_type] => new
[patent_app_number] => 08/981824
[patent_app_country] => US
[patent_app_date] => 1998-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10263
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20020114816.pdf
[firstpage_image] =>[orig_patent_app_number] => 08981824
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/981824 | AUTOREACTIVE PEPTIDES FROM HUMAN GLUTAMIC ACID-DECARBOXYLASE (GAD) | Sep 17, 1998 | Abandoned |
Array
(
[id] => 5800850
[patent_doc_number] => 20020009448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'T-CELL VACCINATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS'
[patent_app_type] => new
[patent_app_number] => 09/156509
[patent_app_country] => US
[patent_app_date] => 1998-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4093
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20020009448.pdf
[firstpage_image] =>[orig_patent_app_number] => 09156509
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/156509 | T-CELL VACCINATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS | Sep 16, 1998 | Abandoned |
Array
(
[id] => 6129490
[patent_doc_number] => 20020076725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'HUMAN T CELL CLONE SPECIFIC FOR RHEUMATOID ARTHRITIS'
[patent_app_type] => new
[patent_app_number] => 09/142755
[patent_app_country] => US
[patent_app_date] => 1998-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7687
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076725.pdf
[firstpage_image] =>[orig_patent_app_number] => 09142755
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/142755 | HUMAN T CELL CLONE SPECIFIC FOR RHEUMATOID ARTHRITIS | Sep 13, 1998 | Abandoned |
Array
(
[id] => 4286174
[patent_doc_number] => 06180084
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-30
[patent_title] => 'NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same'
[patent_app_type] => 1
[patent_app_number] => 9/139802
[patent_app_country] => US
[patent_app_date] => 1998-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 12
[patent_no_of_words] => 37585
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/180/06180084.pdf
[firstpage_image] =>[orig_patent_app_number] => 139802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/139802 | NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same | Aug 24, 1998 | Issued |
Array
(
[id] => 6404741
[patent_doc_number] => 20020037494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'METHOD FOR IDENTIFYING SEX SPECIFIC AND SPECIES SPECIFIC MOLECULES, MOLECULES IDENTIFIED USING THE METHOD, AND USES OF THE MOLECULES'
[patent_app_type] => new
[patent_app_number] => 09/135071
[patent_app_country] => US
[patent_app_date] => 1998-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12864
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037494.pdf
[firstpage_image] =>[orig_patent_app_number] => 09135071
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/135071 | METHOD FOR IDENTIFYING SEX SPECIFIC AND SPECIES SPECIFIC MOLECULES, MOLECULES IDENTIFIED USING THE METHOD, AND USES OF THE MOLECULES | Aug 16, 1998 | Abandoned |
Array
(
[id] => 5967320
[patent_doc_number] => 20020090362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'IMMUNOTHERAPY USING CYTOTOXIC T LYMPHOCYTES (CTL)'
[patent_app_type] => new
[patent_app_number] => 09/101413
[patent_app_country] => US
[patent_app_date] => 1998-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17375
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20020090362.pdf
[firstpage_image] =>[orig_patent_app_number] => 09101413
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/101413 | Immunotherapy using cytotoxic T lymphocytes (CTL) | Aug 6, 1998 | Issued |
Array
(
[id] => 1411323
[patent_doc_number] => 06517839
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-11
[patent_title] => 'Methods for inducing interleukin-12 and a type1/Th1 T-cell response'
[patent_app_type] => B1
[patent_app_number] => 09/118426
[patent_app_country] => US
[patent_app_date] => 1998-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 11340
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/517/06517839.pdf
[firstpage_image] =>[orig_patent_app_number] => 09118426
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/118426 | Methods for inducing interleukin-12 and a type1/Th1 T-cell response | Jul 16, 1998 | Issued |
Array
(
[id] => 4409614
[patent_doc_number] => 06172213
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Anti-IgE antibodies and method of improving polypeptides'
[patent_app_type] => 1
[patent_app_number] => 9/109207
[patent_app_country] => US
[patent_app_date] => 1998-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 45263
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/172/06172213.pdf
[firstpage_image] =>[orig_patent_app_number] => 109207
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/109207 | Anti-IgE antibodies and method of improving polypeptides | Jun 29, 1998 | Issued |
Array
(
[id] => 6617606
[patent_doc_number] => 20020085993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'METHOD FOR IN VITRO PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS'
[patent_app_type] => new
[patent_app_number] => 09/073596
[patent_app_country] => US
[patent_app_date] => 1998-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 27107
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20020085993.pdf
[firstpage_image] =>[orig_patent_app_number] => 09073596
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/073596 | METHOD FOR IN VITRO PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS | May 5, 1998 | Abandoned |
| 09/073109 | MYELIN BASIC PROTEIN PEPTIDES AND USE THEREOF | May 4, 1998 | Abandoned |
| 09/064413 | USE OF IMMUNOTOXINS TO INDUCE IMMUNE TOLERANCE TO PANCREATIC ISLET TRANSPLANTATION | Apr 21, 1998 | Abandoned |
Array
(
[id] => 1533770
[patent_doc_number] => 06488933
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-03
[patent_title] => 'Preparations for the treatment of T cell mediated diseases'
[patent_app_type] => B2
[patent_app_number] => 08/981861
[patent_app_country] => US
[patent_app_date] => 1998-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 6718
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/488/06488933.pdf
[firstpage_image] =>[orig_patent_app_number] => 08981861
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/981861 | Preparations for the treatment of T cell mediated diseases | Apr 18, 1998 | Issued |
Array
(
[id] => 6033368
[patent_doc_number] => 20020019352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'STABLE, ACTIVE, HUMAN OB PROTEIN COMPOSITIONS AND METHODS'
[patent_app_type] => new
[patent_app_number] => 09/059467
[patent_app_country] => US
[patent_app_date] => 1998-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 6388
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019352.pdf
[firstpage_image] =>[orig_patent_app_number] => 09059467
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/059467 | STABLE, ACTIVE, HUMAN OB PROTEIN COMPOSITIONS AND METHODS | Apr 13, 1998 | Abandoned |